[1]
Y. Sirchak, “Neurohormonal changes and intestinal barrier function disorders in irritable bowel syndrome in patients with metabolic-associated fatty liver disease and their correction”, ScienceRise: Medical Science, no. 2(63), pp. 39–49, Oct. 2025.